Landec Corporation Sets First Quarter Fiscal Year 2017 Conference Call for September 28, 2016 at 8 a.m. PT and Earnings Release set for September 27, 2016 After Market

MENLO PARK, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq:LNDC) will hold a conference call on Wednesday, September 28, 2016 at 8 a.m. Pacific time to discuss its results for the first quarter fiscal 2017. Financial results will be reported for the 2017 fiscal first quarter ended August 28, 2016 after market close on September 27, 2016.

Landec's President and CEO, Molly Hemmeter, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.

Date: Wednesday, September 28, 2016
Time: 8 a.m. Pacific time (11 a.m. Eastern time)
Toll Free Participant Dial-in Number: (866) 814-1914
U.S. and International Toll Number: (703) 639-1358
Conference ID: 1675982

Webcast: www.Landec.com/earningscall
The webcast will be available for 30 days through October 28, 2016.

A replay of the teleconference will be available for one week until midnight Eastern time, Wednesday, October 5, 2016.

Toll free replay dial in: 888-266-2081
International replay: 703-925-2533
Replay passcode: 1675982

About Landec Corporation

Landec Corporation (NASDAQ:LNDC) is a leading developer and marketer of proprietary health and wellness solutions within the packaged food and biomaterial markets. Apio, Landec’s food business subsidiary, is the leader in branded, packaged fresh vegetables in North America, utilizing its proprietary BreatheWay® packaging technology to naturally extend the shelf life of fresh produce. Apio combines this technology with the capabilities of a large national fresh produce supplier to offer healthy fresh vegetable products under the Eat Smart® brand to consumers through club and retail grocery stores. Lifecore Biomedical, Landec’s biomaterial business, is a fully integrated Contract Development and Manufacturing Organization (CDMO) that offers expertise and capabilities in fermentation, specialty formulation, aseptic filling and final packaging for FDA regulated medical devices and drugs to customers for applications in a wide array of markets including Ophthalmic, Orthopedic and Oncology. For more information about the company, visit Landec’s website at www.landec.com.

CONTACT: Media and Industry Contact: At the Company: Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations: ICR, Inc. John Mills, Partner (646) 277-1254 John.Mills@ICRINC.com

Source:Landec Corp